Breakthrough in Animal Drug-Delivery Features Covestro's PC Resins
RxActuator’s Mini-Infuser made with Covestro’s PC-based resins said to be the first wearable drug-delivery device for small companion animals.
What is said to be a breakthrough in how veterinarians deliver pain medication to dogs and cats, is the wearable Mini-Infuser Subcutaneous Constant Rate Infusion (SQ-CRI) pump form RxActuator, Tucson, Ariz. Reportedly the first wearable drug delivery device designed for small companion animals, it utilizes PC-based resins from Pittsburgh-based Covestro. By eliminating the possibility of tangled or disconnected IV lines, this device enhances comfort while reducing staff oversight. Additionally, the manufacturer designed this easy-to-use wearable to improve treatment by reducing the risk of medication errors, allowing animals to maintain mobility during drug delivery, and enabling owners to take their pet home
The Mini-Infuser pump case features Covestro’s white Bayblend T85 XF PC+ABS blend. Additionally, clear Makrolon Rx1805 PC in a blue tint is used for the device’s trim. According to Covestro, these materials are easy to mold and offer good chemical and impact resistance--both key attributes for this application. It was among Covestro’s highlights at MD&M West 2020.
“With its wealth of materials and technical knowledge, Covestro was able to recommend the right polycarbonate grades to help us create an innovative and dog-proof drug delivery device for the veterinary industry,” said RxActuator’s chief marketing officer Doug Nutter.. According to the company, the Mini-Infuser is unique in that it achieves constant and reliable infusion without any electronics. Additionally, it is more cost-effective than a regular infusion pump. The device is sold directly in North America and worldwide by RxActuator and distributed by REM Systems in Australia and New Zealand.
U.S. injection molders are still pretty green when it comes to processing the new crop of renewably sourced biopolymers. These biologically derived polymers made from PLA, PHA and starch-based resins are attracting growing market interest as materials with no ties to petrochemical-based thermoplastics.
Polylactic acid, first synthesized a half-century ago, has finally arrived as an alternative to PET, HIPS, PVC, and cellulosics in some high-clarity packaging roles.
To properly understand the differences in performance between PET and PBT we need to compare apples to apples—the semi-crystalline forms of each polymer.